Herein, the remarkable differences of lymphocyte-mediated immunity, interferon gamma signaling, and immune cell invasion between the high- and low-risk group further suggested that targeting tumor ferroptosis-linked metabolism through interferon gamma promotes the efficacy of immunotherapy. This evidence concerns the gene IFNG and neoplasm.